Altamira Therapeutics Ltd. Issued Capital
Altamira Therapeutics Ltd. (CYTOF) had Issued Capital of $11.43 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2025-08-29
- 2023-12-31: Issued Capital 2.65K CHF.
- 2023-06-30: Issued Capital 1.59M CHF.
- 2022-12-31: Issued Capital 236.01K CHF.
- 2022-06-30: Issued Capital 170.64K CHF.
CHF
| Period end | Issued Capital |
|---|---|
| 2023-12-31 | 2.65K CHF 20-F/A · filed 2024-04-22 |
| 2023-06-30 | 1.59M CHF 6-K · filed 2023-09-12 |
| 2022-12-31 | 236.01K CHF 20-F/A · filed 2024-04-22 |
| 2022-06-30 | 170.64K CHF 6-K/A · filed 2023-08-21 |
| 2021-12-31 | 149.64K CHF 6-K/A · filed 2023-08-21 |
| 2021-06-30 | 136.43K CHF 6-K · filed 2021-09-08 |
| 2020-12-31 | 114.17K CHF 20-F · filed 2022-04-12 |
| 2020-06-30 | 50.59K CHF 6-K/A · filed 2020-09-17 |
| 2019-12-31 | 1.65M CHF 20-F · filed 2021-03-31 |
| 2019-06-30 | 1.31M CHF 6-K · filed 2019-08-15 |
| 2018-12-31 | 710.34K CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 19.35M CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 13.73M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Issued Capital |
|---|---|
| 2025-06-30 | $11.43K 6-K · filed 2025-08-29 |
| 2024-12-31 | $9.32K 6-K · filed 2025-08-29 |
| 2024-06-30 | $5.34K 6-K · filed 2024-09-24 |
| 2023-12-31 | $2.96K 20-F · filed 2025-04-30 |
| 2023-01-01 | $267.77K 20-F · filed 2025-04-30 |